Group 1: Industry Overview and Challenges - The domestic ophthalmology medical service industry is gradually emerging from an adjustment period, with increasing demand driven by national policies and a large population base [1][2] - The low penetration rate of various sub-specialties in ophthalmology, coupled with high myopia rates among youth and aging-related eye diseases, presents significant growth opportunities [1][2] Group 2: Business Strategy and Development Plans - The company has initiated a "three-year攻坚" plan focusing on solidifying its foundation, enhancing operational efficiency, and promoting sustainable high-quality development [3][4] - Key strategies include deepening internal growth, advancing technological innovation and digital transformation, consolidating talent and research advantages, and adapting to market and policy changes [3][4][5] Group 3: International Expansion - The company has established a presence in Europe, Southeast Asia, and the United States, with overseas business contributing approximately 13% to total revenue [6] - The international strategy emphasizes adapting to local market conditions and regulatory environments while leveraging domestic expertise in ophthalmology [6] Group 4: Technological Innovation and Research - The company is exploring the application of cutting-edge technologies in visual reconstruction and eye care through strategic partnerships, although these initiatives are still in early stages and unlikely to impact short-term performance [7]